Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.
Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK Jr, Smith PB; Meropenem Study Team. Cohen-Wolkowiez M, et al. Among authors: wade k. Clin Infect Dis. 2012 Dec;55(11):1495-502. doi: 10.1093/cid/cis758. Epub 2012 Sep 5. Clin Infect Dis. 2012. PMID: 22955430 Free PMC article.
Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections.
Smith PB, Cohen-Wolkowiez M, Castro LM, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Bhatt-Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Brozanski BS, Sanchez P, van den Anker J, Blumer J, Kearns GL, Capparelli EV, Anand R, Benjamin DK Jr; Meropenem Study Team. Smith PB, et al. Among authors: wade k. Pediatr Infect Dis J. 2011 Oct;30(10):844-9. doi: 10.1097/INF.0b013e31822e8b0b. Pediatr Infect Dis J. 2011. PMID: 21829139 Free PMC article.
Cefepime and Ceftazidime Safety in Hospitalized Infants.
Arnold CJ, Ericson J, Cho N, Tian J, Wilson S, Chu VH, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act--Pediatric Trials Network Administrative Core Committee. Arnold CJ, et al. Pediatr Infect Dis J. 2015 Sep;34(9):964-8. doi: 10.1097/INF.0000000000000778. Pediatr Infect Dis J. 2015. PMID: 26376308 Free PMC article.
Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.
Ericson JE, Kaufman DA, Kicklighter SD, Bhatia J, Testoni D, Gao J, Smith PB, Prather KO, Benjamin DK Jr; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committeea; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Ericson JE, et al. Clin Infect Dis. 2016 Sep 1;63(5):604-10. doi: 10.1093/cid/ciw363. Epub 2016 Jun 13. Clin Infect Dis. 2016. PMID: 27298330 Free PMC article.
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants.
Ganguly S, Edginton AN, Gerhart JG, Cohen-Wolkowiez M, Greenberg RG, Gonzalez D; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. Ganguly S, et al. Clin Pharmacokinet. 2021 Dec;60(12):1591-1604. doi: 10.1007/s40262-021-01046-6. Epub 2021 Jun 22. Clin Pharmacokinet. 2021. PMID: 34155614 Free PMC article.
Innovative clinical trial design for pediatric therapeutics.
Laughon MM, Benjamin DK Jr, Capparelli EV, Kearns GL, Berezny K, Paul IM, Wade K, Barrett J, Smith PB, Cohen-Wolkowiez M. Laughon MM, et al. Among authors: wade k. Expert Rev Clin Pharmacol. 2011 Sep;4(5):643-52. doi: 10.1586/ecp.11.43. Expert Rev Clin Pharmacol. 2011. PMID: 21980319 Free PMC article. Review.
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants.
Cohen-Wolkowiez M, Sampson M, Bloom BT, Arrieta A, Wynn JL, Martz K, Harper B, Kearns GL, Capparelli EV, Siegel D, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act–Pediatric Trials Network. Cohen-Wolkowiez M, et al. Pediatr Infect Dis J. 2013 Sep;32(9):956-61. doi: 10.1097/INF.0b013e3182947cf8. Pediatr Infect Dis J. 2013. PMID: 23587979 Free PMC article. Clinical Trial.
Population pharmacokinetics of intravenous acyclovir in preterm and term infants.
Sampson MR, Bloom BT, Lenfestey RW, Harper B, Kashuba AD, Anand R, Benjamin DK Jr, Capparelli E, Cohen-Wolkowiez M, Smith PB; Best Pharmaceuticals for Children Act–Pediatric Trials Network. Sampson MR, et al. Pediatr Infect Dis J. 2014 Jan;33(1):42-9. doi: 10.1097/01.inf.0000435509.75114.3d. Pediatr Infect Dis J. 2014. PMID: 24346595 Free PMC article. Clinical Trial.
Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.
Tremoulet A, Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Salgado A, Ian-U Chong S, Melloni C, Gao J, Benjamin DK Jr, Capparelli EV, Cohen-Wolkowiez M; Administrative Core Committee of the Best Pharmaceuticals for Children Act-Pediatric Trials Network. Tremoulet A, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3013-20. doi: 10.1128/AAC.02374-13. Epub 2014 Mar 10. Antimicrob Agents Chemother. 2014. PMID: 24614374 Free PMC article. Clinical Trial.
454 results